Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moleculin Biotech, Inc. - Common Stock (NQ:MBRX)

0.4215 -0.0167 (-3.81%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moleculin Biotech, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week ↗
New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025. 
Via Stocktwits
News headline image
Which stocks are experiencing notable movement on Tuesday? ↗
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Unusual volume stocks in Tuesday's session ↗
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Insights Ahead: Moleculin Biotech's Quarterly Earnings ↗
 
Via Benzinga
News headline image
Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Top 5 Biotech Stocks That Got Most Retail Buzz Last Week ↗
From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter. 
Via Stocktwits
News headline image
Friday's session: top gainers and losers ↗
Here are the top movers in Friday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Check out the stocks that are attracting the most attention and driving market activity. ↗
Let's dive into the action on the US markets on Friday. Here are the most active stocks that are driving the market today. 
Via Chartmill
News headline image
Unusual volume stocks in Friday's session ↗
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. 
Via Chartmill
News headline image
What's going on in today's session ↗
Here are the top movers in Friday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Top movers in Friday's pre-market session ↗
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic' ↗
U.S. stock futures traded close to the flatline on Friday after Tuesday's rally. Futures of all four benchmark indices were slightly lower. 
Via Benzinga
Topics Stocks
News headline image
Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
The trading volume of these stocks is deviating from the norm in today's session. ↗
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
Which stocks are moving on Thursday? ↗
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
Why Is Blood Cancer Focused Moleculin Biotech Stock Trading More Than 400% On Thursday? ↗
Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in late 2025, with another in 2026. 
Via Benzinga
News headline image
Thursday's session: gap up and gap down stocks ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Unusual volume stocks in Wednesday's session ↗
On Wednesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
What's Going On With Moleculin Biotech Shares Wednesday? ↗
Moleculin Biotech shares are trading higher on Wednesday after the company announced the online publication of preclinical data for its Annamycin Venetoclax Resistant AML model. 
Via Benzinga
News headline image
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q2 2024 ↗
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024 ↗
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.